Novel mRNA Lyme Shots Could Be Released in 2025
![Novel mRNA Lyme Shots Could Be Released in 2025 Novel mRNA Lyme Shots Could Be Released in 2025](https://thevaccinereaction.org/wp-content/uploads/2023/08/Lyme-1024x683.jpg)
Two novel messenger RNA (mRNA) shots for Lyme disease currently in late-stage clinical trials could hit the market as early as 2025, Moderna announced earlier this year. Also in the race to develop the first-ever mRNA product to prevent Lyme disease are Pfizer and Austria-based Valneva, which entered into a collaborative agreement in April 2020 […]
German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions
![German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions](https://thevaccinereaction.org/wp-content/uploads/2022/08/reaction-1024x683.jpg)
Techniker Krankenkasse, Germany’s largest health insurance company, reported that 437,593 of 11 million (1 in 25) insured individuals in 2021 had to undergo medical treatment as a result of adverse reactions from COVID-19 shots.1 COVID shots currently approved for use in Germany include Novavax’s Nuvaxovid, Moderna’s Spikevax, Pfizer/BioNTech’s Comirnaty, Johnson & Johnson/Janssen’s Ad26.COV2.S, AstraZeneca/Oxford University’s […]
Another Shot at a Vaccine for Lyme Disease
![Another Shot at a Vaccine for Lyme Disease Another Shot at a Vaccine for Lyme Disease](https://thevaccinereaction.org/wp-content/uploads/2020/11/tick-1024x683.jpg)
The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]
Lyme Disease Vaccines: Past and Future
![Lyme Disease Vaccines: Past and Future Lyme Disease Vaccines: Past and Future](https://thevaccinereaction.org/wp-content/uploads/2019/07/tick-1024x670.jpg)
Story Highlights A new Lyme disease vaccine candidate approved by the FDA using the fast track process is currently in its second phase of clinical trials. In 1998, the FDA granted licensure for a Lyme disease vaccine called LYMErix. Following reports of severe adverse reactions to LYMErix, GlaxoSmithKline (formerly SmithKline Beecham) withdrew the vaccine from […]